ATRS
Antares Pharma, Inc.
ATRS
ATRS
Delisted
ATRS was delisted on the 23rd of May, 2022.
160 hedge funds and large institutions have $312M invested in Antares Pharma, Inc. in 2019 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
+25
Holders Change %
+18.52%
% of All Funds
3.16%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
38
Increased
57
Reduced
40
Closed
13
Calls
$1.04M
Puts
$2.42M
Net Calls
-$1.38M
Net Calls Change
+$10K
Top Buyers
| 1 |
Two Sigma Investments
New York
|
$9.33M |
| 2 |
Millennium Management
New York
|
$8.05M |
| 3 |
Renaissance Technologies
New York
|
$5.38M |
| 4 |
Two Sigma Advisers
New York
|
$6.52M |
| 5 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
$19.2M |
